Pharmacokinetics and safety of apremilast (CC-10004) in subjects with hepatic impairment

Sorry, there's nothing here.

Cite this paper

@article{Assaf2014PharmacokineticsAS, title={Pharmacokinetics and safety of apremilast (CC-10004) in subjects with hepatic impairment}, author={Mahmoud S. Assaf and Eric Laille and Liangang Liu and Edward O'Mara and Anfan Wu and Maria Palmisano and Thomas C. Marbury and Richard A. Preston}, journal={IJMEI}, year={2014}, volume={6}, pages={100-114} }